The global “anticoagulants” market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026. Anticoagulants are widely used across the healthcare industry for the treatment of several cardiovascular and health-related disorders. They are effectively used to treat blood clots avoid blockage of blood flow that is caused due to these drugs.
The demand for anticoagulants has risen dramatically in recent years, owing to its exceptional properties. Anticoagulants are included in major drugs that are prescribed for the treatment of cardiovascular diseases. The properties of anticoagulants have led to a high product adoption in diverse industries. The increasing emphasis on the severe effects of unattended cardiovascular diseases will fuel the demand for anticoagulants.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anticoagulants-market-101807
Highlights of the Anticoagulants Market Report Include:
- Microscopic study of the various factors driving and restraining the market
- Careful classification and research of the market segments
- Accurate computation of market figures
- Comprehensive analysis of the regional dynamics and competitive landscape
Key Players Operating in The Anticoagulants Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Bayer AG
- Janssen Pharmaceuticals, Inc.
- Eisai Co., Ltd.
- Other Prominent Players
The report focuses on global major leading industry players of market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. This report focuses on Anticoagulants Market Trend, volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anticoagulants Market Size by analysing historical data and future prospect.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807
North America to Emerge Dominant; High Prevalence of Cardiovascular Disease to Create Several Growth Opportunities
The market is segmented on the basis of regional demographics into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The high prevalence of cardiovascular disease, coupled with the increasing emphasis on the research and development of new drugs will open up a huge potential for the companies operating in the market in this market. As of 2018, the market in North America was worth USD 10.10 billion. Besides North America, Europe will witness significant growth in the coming years, owing to the high incidence of deaths caused due to cardiovascular disease in several countries across this region. The high demand for anticoagulants in emerging countries such as Germany, France, and UK will have a positive influence on the growth of the market in this region.
Increasing Number of Company Mergers Will Aid Market Growth
Several growth stimulating factors have been analyzed and discussed in detail. Among all factors, the increasing number of company mergers have had the highest impact on the market. In February 2019, Novartis AG and Blackstone’s LifeSciences announced the launch of Anthos Therapeutics. The company is aiming for the research and development of drugs that include anticoagulants as a prime pipeline candidate. Increasing number of drug approvals is another factor that has constituted an increase in the global anticoagulants market size in recent years. Janssen Pharmaceuticals’ Rivaroxaban is an example of a recent drug approval that has had a direct impact on the market.
Objective of Studies:
- To provide strategic profiling of key players in the market, comprehensively analysing their core competencies, and drawing a competitive landscape for the market.
- To provide insights about factors affecting the market growth. To analyse the Anticoagulants Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.
- To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Anticoagulants Market.
- To provide country level analysis of the market with respect to the current Anticoagulants Market size and future prospective.
- To provide country level analysis of the market for segment by application, product type and sub-segments.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
- To track and analyse competitive developments such as joint ventures, strategic alliances, new product developments, and research and developments in the global Anticoagulants Market.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anticoagulants-market-101807
Anticoagulants Market Segmentation:
By Disease Indication
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Atrial Fibrillation
- Heart Attacks
- Others
By Route of Administration
- Oral
- Injectable
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/101807
This Report Answers the Following Questions:
- What are the Anticoagulants Market trends and growth drivers?
- How many segments does the market contain?
- What are the opportunities and challenges that the market may face?
- How are the key players keeping up with the changing consumer behavior?
- What are the latest industry developments?
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245